Related references
Note: Only part of the references are listed.High Protein Diets Improve Liver Fat and Insulin Sensitivity by Prandial but Not Fasting Glucagon Secretion in Type 2 Diabetes
Jiudan Zhang et al.
FRONTIERS IN NUTRITION (2022)
GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells
K. El et al.
SCIENCE ADVANCES (2021)
Repositioning Glucagon Action in the Physiology and Pharmacology of Diabetes
Brian Finan et al.
DIABETES (2020)
A Primary Role for α-Cells as Amino Acid Sensors
E. Danielle Dean
DIABETES (2020)
The role of GIP in α-cells and glucagon secretion
Kimberley El et al.
PEPTIDES (2020)
Selection and progression of unimolecular agonists at the GIP, GLP-1, and glucagon receptors as drug candidates
Patrick J. Knerr et al.
PEPTIDES (2020)
Endogenously released GIP reduces and GLP-1 increases hepatic insulin extraction
Farnaz Keyhani-Nejad et al.
PEPTIDES (2020)
Paracrine control of α-cell glucagon exocytosis is compromised in human type-2 diabetes
Muhmmad Omar-Hmeadi et al.
NATURE COMMUNICATIONS (2020)
'Resistance is futile?' - paradoxical inhibitory effects of KATP channel closure in glucagon-secreting α-cells
Quan Zhang et al.
JOURNAL OF PHYSIOLOGY-LONDON (2020)
High-protein diet more effectively reduces hepatic fat than low-protein diet despite lower autophagy and FGF21 levels
Chenchen Xu et al.
LIVER INTERNATIONAL (2020)
Alpha cell regulation of beta cell function
Tilo Moede et al.
DIABETOLOGIA (2020)
Postprandial Aminogenic Insulin and Glucagon Secretion Can Stimulate Glucose Flux in Humans
Teddy Ang et al.
DIABETES (2019)
The Liver-α-Cell Axis and Type 2 Diabetes
Nicolai J. Wewer Albrechtsen et al.
ENDOCRINE REVIEWS (2019)
Impact of Nutrient Type and Sequence on Glucose Tolerance: Physiological Insights and Therapeutic Implications
Lorenzo Nesti et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial
Mads J. Skytte et al.
DIABETOLOGIA (2019)
The incretin system in healthy humans: The role of GIP and GLP-1
Jens Juul Hoist
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP Production
Jakob G. Knudsen et al.
CELL METABOLISM (2019)
Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion
Elisa Vergari et al.
NATURE COMMUNICATIONS (2019)
β Cell tone is defined by proglucagon peptides through cAMP signaling
Megan E. Capozzi et al.
JCI INSIGHT (2019)
Glucagon lowers glycemia when β cells are active
Megan E. Capozzi et al.
JCI INSIGHT (2019)
Rate of appearance of amino acids after a meal regulates insulin and glucagon secretion in patients with type 2 diabetes: a randomized clinical trial
Mariya Markova et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2018)
High Glycemic Index Metabolic Damage - a Pivotal Role of GIP and GLP-1
Andreas F. H. Pfeiffer et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)
Insulin Secretion Depends on Intra- islet Glucagon Signaling
Berit Svendsen et al.
CELL REPORTS (2018)
Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes
Mariya Markova et al.
GASTROENTEROLOGY (2017)
Effects of Palatinose and Sucrose Intake on Glucose Metabolism and Incretin Secretion in Subjects With Type 2 Diabetes
Farnaz Keyhani-Nejad et al.
DIABETES CARE (2016)
Human Beta Cells Produce and Release Serotonin to Inhibit Glucagon Secretion from Alpha Cells
Joana Almaca et al.
CELL REPORTS (2016)
The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions
Michael A. Nauck et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients
Daisuke Yabe et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2015)
Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals
Jonatan I. Bagger et al.
DIABETOLOGIA (2014)
Role of KATP Channels in Glucose-Regulated Glucagon Secretion and Impaired Counterregulation in Type 2 Diabetes
Quan Zhang et al.
CELL METABOLISM (2013)
Minireview: Glucagon in the Pathogenesis of Hypoglycemia and Hyperglycemia in Diabetes
Philip E. Cryer
ENDOCRINOLOGY (2012)
Impaired Crosstalk between Pulsatile Insulin and Glucagon Secretion in Prediabetic Individuals
Stefan Rohrer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover
Roger H. Unger et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes
Asger Lund et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Loss of Inverse Relationship Between Pulsatile Insulin and Glucagon Secretion in Patients With Type 2 Diabetes
Bjoern A. Menge et al.
DIABETES (2011)
Glucose-Dependent Insulinotropic Polypeptide A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans
Mikkel Christensen et al.
DIABETES (2011)
GIP Does Not Potentiate the Antidiabetic Effects of GLP-1 in Hyperglycemic Patients With Type 2 Diabetes
Nikolaos Mentis et al.
DIABETES (2011)
Regulation of glucagon secretion by incretins
J. J. Holst et al.
DIABETES OBESITY & METABOLISM (2011)
Paracrinology of islets and the paracrinopathy of diabetes
Roger H. Unger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Insulin Signaling in α Cells Modulates Glucagon Secretion In Vivo
Dan Kawamori et al.
CELL METABOLISM (2009)
Incretin and islet hormonal responses to fat and protein ingestion in healthy men
Richard D. Carr et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects
J. J. Meier et al.
DIABETOLOGIA (2007)
Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion -: Further evidence for the intraislet insulin hypothesis
JJ Meier et al.
DIABETES (2006)
Glucose inhibition of glucagon secretion from rat α-cells is mediated by GABA released from neighboring β-cells
A Wendt et al.
DIABETES (2004)
Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia
JJ Meier et al.
DIABETOLOGIA (2003)
Share Paper
